- Home
- WKHS vs MAIA Comparison
WKHS vs MAIA Comparison
Compare WKHS & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKHS
- MAIA
- Stock Information
- Founded
- WKHS 2007
- MAIA 2018
- Country
- WKHS United States
- MAIA United States
- Employees
- WKHS N/A
- MAIA N/A
- Industry
- WKHS Auto Manufacturing
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- WKHS Consumer Discretionary
- MAIA Health Care
- Exchange
- WKHS Nasdaq
- MAIA Nasdaq
- Market Cap
- WKHS 20.0M
- MAIA 56.3M
- IPO Year
- WKHS N/A
- MAIA 2022
- Fundamental
- Price
- WKHS $1.11
- MAIA $1.54
- Analyst Decision
- WKHS Hold
- MAIA
- Analyst Count
- WKHS 2
- MAIA 0
- Target Price
- WKHS $8.68
- MAIA N/A
- AVG Volume (30 Days)
- WKHS 756.2K
- MAIA 469.2K
- Earning Date
- WKHS 08-15-2025
- MAIA 11-11-2025
- Dividend Yield
- WKHS N/A
- MAIA N/A
- EPS Growth
- WKHS N/A
- MAIA N/A
- EPS
- WKHS N/A
- MAIA N/A
- Revenue
- WKHS $10,745,014.00
- MAIA N/A
- Revenue This Year
- WKHS $92.70
- MAIA N/A
- Revenue Next Year
- WKHS $34.00
- MAIA N/A
- P/E Ratio
- WKHS N/A
- MAIA N/A
- Revenue Growth
- WKHS 11.73
- MAIA N/A
- 52 Week Low
- WKHS $0.81
- MAIA $1.40
- 52 Week High
- WKHS $24.25
- MAIA $3.48
- Technical
- Relative Strength Index (RSI)
- WKHS 31.22
- MAIA 45.86
- Support Level
- WKHS $1.13
- MAIA $1.54
- Resistance Level
- WKHS $1.34
- MAIA $1.78
- Average True Range (ATR)
- WKHS 0.07
- MAIA 0.09
- MACD
- WKHS -0.00
- MAIA 0.01
- Stochastic Oscillator
- WKHS 3.57
- MAIA 25.00
About WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.